Market Place
Sourcing Support
Everest to continue mRNA ascent alone, ending Providence collab
20 Feb 2024 //
FIERCE BIOTECH
Providence Therapeutics Announces Partnership with UHN
02 Jun 2023 //
GLOBENEWSWIRE
Providence Therapeutics Appoints Robert Georgantas as President and CTO
01 Feb 2023 //
GLOBENEWSWIRE
Providence Therapeutics Announces New mRNA Rabies Vaccine Program
15 Dec 2022 //
GLOBENEWSWIRE
Providence Presents PII Data on mRNA COVID-19 Vaccine Candidate PTX-COVID19-B
28 Nov 2022 //
GLOBENEWSWIRE
Providence Therapeutics Appoints Judyanna Yu as CFO
02 Nov 2022 //
PRESS RELEASE
Providence Announces Positive Data from PII Immunization Trial of PTX-COVID19-B
19 Oct 2022 //
GLOBENEWSWIRE
After matching Comirnaty, Providence plans phase 3 booster study
19 Oct 2022 //
FIERCEBIOTECH
Providence, Everest`s PTX-COVID19-B approved for inclusion in WHO STV Program
20 Dec 2021 //
PRNEWSWIRE
Providence announces $2.118M in funding to support PTX-COVID19-B program
07 Dec 2021 //
PRNEWSWIRE
Emergent to make Providence Therapeutics potential COVID-19 vaccine
15 Sep 2021 //
REUTERS
Northern RNA and Providence Therapeutics Announce Multi-Year Agreement
14 Sep 2021 //
NEWSWIRE
Providence announces PTX-COVID19-B, neutralizes SARS-CoV-2 and variants
14 Sep 2021 //
PHARMABIZ
Everest bags COVID-19 assets in bid to conquer mRNA market
14 Sep 2021 //
FIERCEBIOTECH
Everest & Providence Sign Agreement to Advance mRNA Vaccines and Therapies
13 Sep 2021 //
PRNEWSWIRE
Study On Remdesivir Reinforces Need To Define Optimal Treatment Of Covid-19
19 Aug 2021 //
PRNEWSWIRE
Providence Therapeutics Holdings Inc. Of Canada And Biological E. Limited
01 Jun 2021 //
BIOLOGICALE
Providence Therapeutics Enters into Agreement with Government of Manitoba
11 Feb 2021 //
NEWSWIRE
Providence Therapeutics announces first subject has been dosed in COVID-19
26 Jan 2021 //
NEWSWIRE
Providence Therapeutics Welcomes Funding from NGen to Bolster COVID-19 Vaccine
21 Jan 2021 //
NEWSWIRE
Providence Therapeutics COVID-19 Vaccine Receives Health Canada
23 Dec 2020 //
NEWSWIRE
Providence COVID-19 Vaccine Receives Health Canada to Begin Clinical Trials
23 Dec 2020 //
NEWSWIRE
Providence Therapeutics Submits Clinical Trial Application (CTA)
04 Dec 2020 //
NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.